The Federal Government is changing the way new medicines are approved to ensure Australians get access to breakthrough drugs more quickly.
At the moment, Australian patients are being forced to wait up to two years longer to access some drugs than patients in the United States and Europe.
Under the changes being announced today, any drug that has been listed by a comparable overseas regulator, including the US Food and Drug Administration and the European Medicines Agency, can now be fast-tracked for approval and sale in Australia.
Health Minister Sussan Ley said the Therapeutic Goods Administration (TGA) would be able to share information with those overseas regulators, meaning it would no longer have to start the lengthy approvals process from scratch, in every case.
“What we need to do is accept the evidence that is being presented to those overseas regulators, bring that information to Australia, ensure our TGA is happy and ultimately list those medicines earlier,” she said.
“Ultimately this is all about consumers getting access to medicines earlier.”
Ms Ley said while regulators in the US and Europe were of the highest quality, the TGA would continue to have the final say over whether drugs were made available in Australia.
The regulatory changes would also allow pharmaceutical companies to list their drugs in Australia at the same time as they list them in larger, overseas markets, she said.
“Ultimately we know pharmaceutical companies tend to list where the market is larger, the patient number is larger and they’re going to sell more of the drug,” Ms Ley said.
“Often that means Australia has missed out but we don’t want to miss out, we want access to that drug.”
The Government allocated $20.4 million in the May budget to implement the changes, which will be rolled out over the next two years.
Referenced by political reporter Jane Norman
Comments are closed.
March 16th, 2020
October 14th, 2019
Sleep snapshot: Do you sleep like a baby or struggle to get your shuteye?
September 16th, 2019
July 22nd, 2019
Smartphone app could replace traditional atrial fibrillation detection in outback Australia
September 26th, 2016
Emergency Community Care Positions – Phase 2
September 16th, 2016
HCF Invests $1 Million Into Innovative Australian Technology Business, Curo
September 15th, 2016
New medicine approval process to allow quicker access to breakthrough drugs
September 14th, 2016
Caring for people with Dementia – Workshop
September 6th, 2016
September 1st, 2016
Suite 117, 838 Collins Street
Docklands
3008
1300 1 HOBSON
jobs@hobsonhr.com.au
accounts@hobsonhr.com.au
Copyright © 2022 Hobson HR. ABN 21 933 896 904
Hobson Health Recruitment Pty Ltd acknowledges Aboriginal and Torres Strait Islander Peoples as the First Australians. We acknowledge the diversity of Aboriginal and Torres Strait Islander Peoples across this land. We respectfully recognise Elders both past and present.